Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
暂无分享,去创建一个
Guillermina Lozano | R. Hakem | G. Lozano | J. Parant | Yunping Lin | Weili Ma | S. Benchimol | R. Leng | Hong Wu | B. Lemmers | S. Chung | Roger P. Leng | Yunping Lin | Weili Ma | Hong Wu | Benedicte Lemmers | Stephen Chung | John M. Parant | Razqallah Hakem | Samuel Benchimol | Roger P Leng
[1] D. Pim,et al. Monoclonal antibodies specific for simian virus 40 tumor antigens , 1981, Journal of virology.
[2] Stephen W. Hawking,et al. On The Shoulders Of Giants , 2016 .
[3] E. Shaulian,et al. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding , 1992, Molecular and cellular biology.
[4] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Shengyun Fang,et al. Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.
[6] A. Jochemsen,et al. MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.
[7] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[8] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[9] Hirofumi Tanaka,et al. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.
[10] M. Jackson,et al. MdmX Protects p53 from Mdm2-Mediated Degradation , 2000, Molecular and Cellular Biology.
[11] S. Elledge,et al. How the Cyclin Became a Cyclin Regulated Proteolysis in the Cell Cycle , 1999, Cell.
[12] Delin Chen,et al. Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.
[13] Valerie Reinke,et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.
[14] S. Benchimol,et al. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin , 1993, Molecular and cellular biology.
[15] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[16] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[17] J. Manfredi,et al. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. , 1998, Genes & development.
[18] K. Vousden. Activation of the p53 tumor suppressor protein. , 2002, Biochimica et biophysica acta.
[19] M. Oren,et al. mdm 2 expression is induced by wild type p 53 activity , 2004 .
[20] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[21] M. Oren,et al. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. , 1993, Oncogene.
[22] K. Borden. RING domains: master builders of molecular scaffolds? , 2000, Journal of molecular biology.
[23] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[24] R. Weinberg,et al. hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.
[25] C. Prives,et al. Why Is p53 Acetylated? , 2001, Cell.
[26] L. Banks,et al. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. , 1986, European journal of biochemistry.
[27] M. Pincus,et al. Conformation-dependent phosphorylation of p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Honda,et al. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase , 2000, Oncogene.
[29] S. Wing,et al. Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity. , 2002, Journal of molecular endocrinology.
[30] Delin Chen,et al. Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.
[31] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[32] A. Levine,et al. Mapping of the p53 and mdm-2 interaction domains. , 1993, Molecular and cellular biology.
[33] V. Adler,et al. JNK targets p53 ubiquitination and degradation in nonstressed cells. , 1998, Genes & development.
[34] S. Fang,et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[36] A. Yang,et al. On the shoulders of giants: p63, p73 and the rise of p53. , 2002, Trends in genetics : TIG.
[37] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[38] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[39] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[40] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[41] Zhi-Min Yuan,et al. Identification of a Sequence Element from p53 That Signals for Mdm2-Targeted Degradation , 2000, Molecular and Cellular Biology.
[42] W. Kaelin,et al. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. , 2001, Genes & development.
[43] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[44] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.